A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)

Condition:   Acromegaly Interventions:   Drug: Paltusotine;   Drug: Placebo Sponsor:   Crinetics Pharmaceuticals Inc. Recruiting

Source: ClinicalTrials.gov - January 14, 2022 Category: Research Source Type: clinical trials